Two British infants, 11 and 16 months old, have been cured of leukemia Both have been in remission for at least a year post-treatment London doctors used genetically engineered immune cells to treat the cancer This could lead to off-the-shelf cellular therapy at a low cost for future patients Two babies who were...
Post
The immunotherapy, pembrolizumab, is active against mucosal melanoma tumors
And prolongs survival for patients with bladder cancer Amsterdam, The Netherlands: Clinical trials of a new immunotherapy, pembrolizumab, have shown that it prolongs life significantly for patients with bladder cancer and is active against a rare sub-type of melanoma, called mucosal melanoma. The findings were presented in two presentations at the European Cancer Congress 2017...